New drug could help seriously ill prostate cancer patients live for two years longer - Independent.ie

Prostate cancer patients, whose disease has spread to other organs, can now expect to live on average two years longer when the drug enzalutamide is added to their treatment.

Prostate cancer patients, whose disease has spread to other organs, can now expect to live on average two years longer when the drug enzalutamide is added to their treatment. This is according to th… [+2838 chars]

full article...